Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Bristol-Myers Squibb revenue
Bristol-Myers Squibb's revenue is $48.3 billion.
What is Bristol-Myers Squibb's revenue?
- Bristol-Myers Squibb annual revenue for 2023 was 45.0B, -2.5% growth from 2022.
- Bristol-Myers Squibb annual revenue for 2024 was 48.3B, 7.32% growth from 2023.
- Bristol-Myers Squibb's revenue growth from 1998 to 2024 is 220.7%.
- Bristol-Myers Squibb has 30,000 employees, and the revenue per employee ratio is $1,610,000.
- Bristol-Myers Squibb's peak quarterly revenue was $12.3B in 2024(q4).
- Bristol-Myers Squibb peak revenue was $48.3B in 2024.
On this page
Zippi applies for you, and finds you a job.
Bristol-Myers Squibb historical revenue
Bristol-Myers Squibb's peak revenue was $48.3B in 2024. The peak quarterly revenue was $12.3B in 2024(q4).
Bristol-Myers Squibb's revenue increased from $15.1b in 1998 to $48.3B currently. That's a 220.7% change in annual revenue.
Bristol-Myers Squibb annual revenue
Bristol-Myers Squibb annual revenue over time
| Fiscal year / year | Bristol-Myers Squibb revenue |
|---|---|
| 2009 | $18.8B |
| 2010 | $19.5B |
| 2011 | $21.2B |
| 2012 | $17.6B |
| 2013 | $16.4B |
| 2014 | $15.9B |
| 2015 | $16.6B |
| 2016 | $19.4B |
| 2017 | $20.8B |
| 2018 | $22.6B |
| 2019 | $26.1B |
| 2020 | $42.5B |
| 2021 | $46.4B |
| 2022 | $46.2B |
| 2023 | $45.0B |
| 2024 | $48.3B |
Rate Bristol-Myers Squibb's financial transparency
Bristol-Myers Squibb annual growth
Bristol-Myers Squibb saw the greatest revenue growth in 2020, when revenue increased by 62.62%.
Bristol-Myers Squibb had the lowest revenue growth in 2012, when revenue changed by -17.05%.
Bristol-Myers Squibb annual growth rate over time
| Year | Bristol-Myers Squibb growth |
|---|---|
| 2009 | 6%↑ |
| 2010 | 4%↑ |
| 2011 | 9%↑ |
| 2012 | -17%↓ |
| 2013 | -7%↓ |
| 2014 | -3%↓ |
| 2015 | 4%↑ |
| 2016 | 17%↑ |
| 2017 | 7%↑ |
| 2018 | 9%↑ |
| 2019 | 16%↑ |
| 2020 | 63%↑ |
| 2021 | 9%↑ |
| 2022 | -0%↓ |
| 2023 | -2%↓ |
| 2024 | 7%↑ |
Bristol-Myers Squibb quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Bristol-Myers Squibb quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $4.3B | $4.7B | $4.8B | $5.0B |
| 2010 | $4.8B | $4.8B | $4.8B | $5.1B |
| 2011 | $5.0B | $5.4B | $5.3B | $5.5B |
| 2012 | $5.3B | $4.4B | $3.7B | $4.2B |
| 2013 | $3.8B | $4.0B | $4.1B | $4.4B |
| 2014 | $3.8B | $3.9B | $3.9B | $4.3B |
| 2015 | $4.0B | $4.2B | $4.1B | $4.3B |
| 2016 | $4.4B | $4.9B | $4.9B | $5.2B |
| 2017 | $4.9B | $5.1B | $5.3B | $5.4B |
| 2018 | $5.2B | $5.7B | $5.7B | $6.0B |
| 2019 | $5.9B | $6.3B | $6.0B | $7.9B |
| 2020 | $10.8B | $10.1B | $10.5B | $11.1B |
| 2021 | $11.1B | $11.7B | $11.6B | $12.0B |
| 2022 | $11.6B | $11.9B | $11.2B | $11.4B |
| 2023 | $11.3B | $11.2B | $11.0B | $11.5B |
| 2024 | $11.9B | $12.2B | $11.9B | $12.3B |
Bristol-Myers Squibb jobs nearby
Do you work at Bristol-Myers Squibb?
Did Bristol-Myers Squibb meet its revenue projections?
Bristol-Myers Squibb financial information
| CEO | Giovanni Caforio |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 30,000 |
| Date Founded | 1887 |
| Headquarters | New York, New York |
| Number of Locations | 27 |
| Revenue | $48.3B |
| Net Income | $6,327,000,000 |
| Gross Proft | $34.3B (2024) |
| PE Ratio | -9.75 |
| Tax Rate | -0.1% |
| Market Capitalization | $87.3B |
| Total Assets | $96,820,000,000 |
| Ticker | BMY |
Bristol-Myers Squibb jobs you might like
Bristol-Myers Squibb financing
Bristol-Myers Squibb received early financing of $80.0M on 2017-02-21.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $80M | 02/2017 |
| Post Ipo Debt | $6B | 02/2022 |
Bristol-Myers Squibb investors
| Investors | Security type |
|---|---|
| Gregory Bailey | Post Ipo Equity |
| Venrock | Post Ipo Equity |
| Litmore Capital | Post Ipo Equity |
| John W. Childs | Post Ipo Equity |
| Aisling Capital | Post Ipo Equity |
| Carl Icahn | Post Ipo Equity |
| Connecticut Innovations | Post Ipo Equity |
| Knoll Capital Management | Post Ipo Equity |
| Osage University Partners | Post Ipo Equity |
| Vivo Capital | Post Ipo Equity |
| Aperture Venture Partners | Post Ipo Equity |
| Rock Springs Capital | Post Ipo Equity |
| RA Capital Management | Post Ipo Equity |
Bristol-Myers Squibb competitors
Bristol-Myers Squibb's top competitor, Johnson & Johnson, earned an annual revenue of $88.8B.
Bristol-Myers Squibb's smallest competitor is Bayer with revenue of $17.0B last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Merck | $90,328 | $64.2B | 74,000 | 2,471 |
| Johnson & Johnson | $76,686 | $88.8B | 134,500 | 1,051 |
| Eli Lilly and Company | $100,905 | $45.0B | 33,625 | 631 |
| Pfizer | $70,868 | $63.6B | 78,500 | 389 |
| Boehringer Ingelheim | $106,981 | $17.2B | 52,391 | 390 |
| AstraZeneca | $112,988 | $25.9B | 76,100 | 33 |
| Glaxosmithkline | $68,587 | $34.1B | 99,000 | - |
| AbbVie | $107,969 | $56.3B | 47,000 | 1,397 |
| Bayer | $89,204 | $17.0B | 20,735 | 1,542 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Bristol-Myers Squibb highest paying jobs
Zippia gives an in-depth look into the details of Bristol-Myers Squibb, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Bristol-Myers Squibb. The employee data is based on information from people who have self-reported their past or current employments at Bristol-Myers Squibb. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Bristol-Myers Squibb. The data presented on this page does not represent the view of Bristol-Myers Squibb and its employees or that of Zippia.
Bristol-Myers Squibb may also be known as or be related to Bristol Myers Squibb, Bristol-Myers Company (1933–1989) Bristol-Myers Squibb Company (1989–2020), Bristol-Myers Squibb, Bristol-Myers Squibb Company, Bristol-Myers Squibb Foundation and bristol meyers squibb.